Medicenna Therapeutics Corp. (TSX:MDNA)
Canada
· Delayed Price · Currency is CAD 0.570
-0.040 (-6.56%)
Apr 28, 2026, 3:59 PM EST
Medicenna Therapeutics Market Cap
Medicenna Therapeutics has a market cap or net worth of CAD 47.55 million as of April 28, 2026. Its market cap has decreased by -34.63% in one year.
Market Cap
47.55M
Enterprise Value
37.07M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.57
Market Cap Chart
Since March 8, 2017, Medicenna Therapeutics's market cap has decreased from 65.63M to 47.55M, a decrease of -27.55%. That is a compound annual growth rate of -3.46%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NurExone Biologic | 54.31M |
| Sernova Biotherapeutics | 62.36M |
| Sharp Therapeutics | 63.16M |
| Defence Therapeutics | 42.33M |
| MedMira | 42.10M |
| ME Therapeutics Holdings | 75.12M |
| BriaCell Therapeutics | 38.43M |
| Telescope Innovations | 37.98M |